Isofol Medical AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 0.721 million compared to SEK 4.01 million a year ago. Revenue was SEK 0.745 million compared to SEK 4.01 million a year ago.

Net loss was SEK 14.4 million compared to SEK 47.87 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.3 a year ago. Diluted loss per share from continuing operations was SEK 0.09 compared to SEK 0.3 a year ago.